Caricamento...
A combined opiate agonist and antagonist treatment reduces prolactin secreting pituitary tumor growth
Prolactin secreting pituitary adenomas (prolactinomas) is the most common pituitary tumors in humans. Animal studies have identified aggressive prolactinoma development in fetal alcohol exposed rats. We have recently identified a combination treatment of a μ opioid receptor antagonist naltrexone and...
Salvato in:
| Pubblicato in: | J Cell Commun Signal |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Netherlands
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5559393/ https://ncbi.nlm.nih.gov/pubmed/28144772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12079-017-0374-x |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|